Anixa Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Anixa Biosciences's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 100% to $210,000. The net income raised on -$9,811,000 and profit margin reached -4672%. Total operating expenses were $11,060,000.

Profit Margin

Anixa Biosciences, Inc. (NASDAQ:ANIX): Profit margin
2014 3.66M -9.60M -261.94%
2015 9.25M -1.37M -14.9%
2016 300K -5.01M -1672.14%
2017 362.5K -5.00M -1381.79%
2018 1.11M -13.99M -1258.07%
2019 250K -11.99M -4797.78%
2020 0 -10.13M
2021 512.5K -12.94M -2526.17%
2022 2.46B -13.49M -0.55%
2023 210K -9.81M -4671.9%

ANIX Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
210K2.46B512.5K0250K1.11M362.5K300K9.25M3.66M
Cost of revenue
161K42K385.00K90.15K166.25K768.41K104.55K217.41K3.64M1.98M
Gross profit
49K2.46B127.49K-90.15K83.75K344.09K257.94K82.58K5.60M1.67M
Operating exp.
Research and development
4.76M6.70M6.18M4.38M5.47M6.81M1.59M1.55M711.39K1.18M
Selling and marketing
0000000000
Total operating expenses
11.06M13.87M13.26M9.97M11.55M14.05M6.33M4.59M6.55M6.72M
Operating income
-11.01M-13.87M-13.13M-9.97M-11.47M-14.28M-6.07M-4.50M-944.75K-5.04M
Other income (expenses), net
1.08M104K7.76K-114.16K-347.39K-582.97K1.06M-507.41K-434.28K-4.56M
Income before tax
-9.93M-13.77M-13.12M-10.09M-11.81M-14.24M-5.00M-5.01M-1.37M-9.60M
Income tax expense
0-280K-181.29K40.15K175.79K289.94K500.45K12.53K17.62K1.26M
Net income
-9.81M-13.49M-12.94M-10.13M-11.99M-13.99M-5.00M-5.01M-1.37M-9.60M
Earnings per share
Basic EPS
-0.32-0.44-0.45-0.46-0.61-0.79-0.41-0.57-0.14-1
Diluted EPS
-0.32-0.44-0.45-0.46-0.61-0.79-0.41-0.57-0.14-1
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source